Ceritinib overcomes proteasome inhibitor resistance in multiple myeloma by suppressing the protein folding response
- DOI
- 10.3929/ethz-c-000807575
- Published
- 2026
- Container
- Not recorded
- Publisher
- Fondazione Ferrata Storti
- Open access
- yes
Credibility signals
limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by-nc/4.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3929/ethz-c-000807575,
title = {Ceritinib overcomes proteasome inhibitor resistance in multiple myeloma by suppressing the protein folding response},
author = {Besse, Andrej and Kraus, Marianne and Totu, Tiberiu and Buljan, Marija and Janssen, Antonius P.A. and Van der Stelt, Mario and Matisikova, Karin and Veprkova, Jana and Sedlarikova, Lenka and Jurinakova, Tamara and Truger, Marietta and Haferlach, Claudia and Mendez Lopez, Max and Kortum, Martin K. and Rasche, Leo and Driessen, Christoph and Besse, Lenka},
year = {2026},
doi = {10.3929/ethz-c-000807575},
url = {https://doi.org/10.3929/ethz-c-000807575}
}RIS
TY - JOUR TI - Ceritinib overcomes proteasome inhibitor resistance in multiple myeloma by suppressing the protein folding response AU - Besse, Andrej AU - Kraus, Marianne AU - Totu, Tiberiu AU - Buljan, Marija AU - Janssen, Antonius P.A. AU - Van der Stelt, Mario AU - Matisikova, Karin AU - Veprkova, Jana AU - Sedlarikova, Lenka AU - Jurinakova, Tamara AU - Truger, Marietta AU - Haferlach, Claudia AU - Mendez Lopez, Max AU - Kortum, Martin K. AU - Rasche, Leo AU - Driessen, Christoph AU - Besse, Lenka PY - 2026 DO - 10.3929/ethz-c-000807575 UR - https://doi.org/10.3929/ethz-c-000807575 ER -
APA
Andrej, B., Marianne, K., Tiberiu, T., Marija, B., P.A., J. A., Mario, V. D. S., Karin, M., Jana, V., Lenka, S., Tamara, J., Marietta, T., Claudia, H., Max, M. L., K., K. M., Leo, R., Christoph, D., & Lenka, B. (2026). Ceritinib overcomes proteasome inhibitor resistance in multiple myeloma by suppressing the protein folding response. https://doi.org/10.3929/ethz-c-000807575
Source records
- datacite · retrieved 2026-11-10T18:01:44.394Z